Hematologic adverse events
| Cytopenias grade 3-4 . | Total, no. (%) . | Imatinib-resistant, no. (%) . | Imatinib-intolerant, no. (%) . |
|---|---|---|---|
| All patients | 107 (100) | 99 (100) | 8 (100) |
| Leukopenia | 65 (61) | 59 (60) | 6 (75) |
| Thrombocytopenia | 88 (82) | 81 (82) | 7 (88) |
| Neutropenia | 83 (76) | 75 (76) | 8 (100) |
| Anemia | 74 (69) | 67 (68) | 7 (88) |
| Cytopenias grade 3-4 . | Total, no. (%) . | Imatinib-resistant, no. (%) . | Imatinib-intolerant, no. (%) . |
|---|---|---|---|
| All patients | 107 (100) | 99 (100) | 8 (100) |
| Leukopenia | 65 (61) | 59 (60) | 6 (75) |
| Thrombocytopenia | 88 (82) | 81 (82) | 7 (88) |
| Neutropenia | 83 (76) | 75 (76) | 8 (100) |
| Anemia | 74 (69) | 67 (68) | 7 (88) |